SUMMARY
It is well established that interferon-alpha can induce non-cytotoxic intracellular suppression of hepatitis B virus replication, but the mechanisms involved are unclear. Cell culture studies to characterize these mechanisms are restricted, in part because hepatitis B virus replicates almost exclusively in liver-derived cells. To overcome this limitation we used a CMVpromoter controlled hepatitis B virus expression system, which leads to intracellular viral replication even in non-hepatic cell lines. In this experimental system interferon-alpha treatment specifically suppressed viral replication demonstrating that antiviral activities against hepatitis B virus are not restricted to hepatic cells. Furthermore, the interferoninducible MxA protein was recently reported to play a key role in the antiviral action of interferon-alpha against hepatitis B virus. Our data demonstrate that interferon-alpha also suppresses hepatitis B virus replication in MxA-deficient HEp2 cells, indicating that MxA is not essential for these activities. Taken together, our data imply that the experimental approach presented can also be adapted to established cell lines which are deficient in parts of the signal transduction pathway or other elements located further downstream, providing important insights into mechanisms specifically suppressing hepatitis B virus. Expression of SEAP was used to standardize efficiency of transfection and to monitor potential IFNα-mediated cytotoxic effects.
Cell culture and transfections
The human hepatoma (Huh7) and the human cervix carcinoma (HEp2) cell lines were grown as monolayer in Dulbecco´s modified Eagle medium supplemented with 10% fetal calf serum. Plasmid DNAs used for transfection were purified by ion exchange chromatography and transfected using (1,000 IU/ml, Intron A, Essex Pharma, Munich, Germany) for 48 h and harvested for analysis afterwards. The amount of SEAP activity secreted into the medium of transfected cells was determined by quantification of the SEAP activity as increase of the optical density at 405 nm x 10 -3 per min (mOD/min) as described previously (17) .
Purification of HBV-DNA from intracellular core particles and Southern blot analysis
Isolation of HBV-DNA from cytoplasmic core particles was performed as described recently (18) . DNA was separated on a 1.2% agarose gel, blotted onto Hybond N nylon membranes (Amersham, International plc, Buckinghamshire, England) and hybridized with a 32 P-labelled full-length HBV-DNA fragment. Blots were exposed to Fuji imaging screens and signals were quantified by a Fujix BAS 2000 bio-imaging analyzer (Fuji, Tokyo, Japan) and by TINA software (Raytest, Straubenhardt, Germany).
Western blot analysis
Protein extracts were prepared as described previously (17) . Extracts were separated by use of (Fig 1) . The expression levels of the cotransfected control gene SEAP were not affected by the IFNα-treatment (Fig 1) , by guest on October 5, 2017
